In 2026, Barbados will reach its 60th anniversary. For Barbadians, our biggest challenge is poor health, specifically non-communicable diseases like ...

MISSOULA — (MPH) invites the public to attend a free screening of the film “Someone You Love: The HPV Epidemic” on Wednesday, March 4, at 6 p.m.

Phase 1b expansion cohort data evaluating 2000mg of ficerafusp alfa every other week in combination with pembrolizumab in 1L HPV-negative R/M HNSCC patients demonstrate rapid, deep and durable respons ...

Breast exams, birth control and family planning are just some of the reasons not to skip your annual ob-gyn appointment.

Dr Samuel Kaba Akoriyea, Director-General of the Ghana Health Service (GHS), has visited the Cervical Cancer Prevention and Training ...

Giva is set to raise Rs 110 crore (around $12 million) in its Series C extension round led by HPV CC1 ltd, with the participation from Premji Invest, Kenro Capital, and Titan Capital.

Upstate Cancer Center’s beneath the surFACE program focuses on HPV education and prevention awareness. It hosts local high school art students who decorate radiation masks to raise money for the ...

The FDA granted breakthrough therapy designation to Rybrevant Faspro based on data from the phase 1b/2 OrigAMI-4 study (NCT06385080).

The IMMUNEBOOST-HPV trial investigated whether adding nivolumab (Opdivo) immunotherapy before standard chemoradiation could improve outcomes for patients with high-risk oropharyngeal cancer. Although ...

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for subcutaneous Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as a monotherapy for adults with advanced ...